Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Vaxcyte to Present at Guggenheim Emerging Outlook

Digest more
Top News
Overview
 · 2d
Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook: Biotech Summit 2026
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph...

Continue reading

TMCnet · 1d
Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
Joplin Globe · 2d
Immunome to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
TMCnet
TMCnet · 1d
Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Emerging Outlook: Biotech Summit 2026
Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact therapies in autoimmune diseases and canc...

Continue reading

 · 1d
Apogee Therapeutics to Participate at the Guggenheim Emerging Outlook: Biotech Summit 2026
 · 1d
Rhythm Pharmaceuticals Announces Participation in Upcoming Guggenheim Biotech Summit
GovCon Wire
7mon

Guggenheim Securities Managing Director Andy McEnroe Receives 2025 Wash100 Award

Andy McEnroe, managing director at Guggenheim Securities, received the 2025 Wash100 Award from Executive Mosaic CEO Jim Garrettson. The seasoned government investment banker was recognized with his first Wash100 accolade for his significant market insights ...
Seeking Alpha
2mon

Maze Therapeutics, Inc. (MAZE) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript

Thank you for joining Guggenheim's 2025 Healthcare Innovations Conference. I am Debjit, one of the therapeutic analysts and are my privilege to host our next presenting company, Maze Therapeutics. And joining us from Maze is Jason Coloma, the CEO.
FOX40 News
6mon

Guggenheim Securities Hires Joel Fishbein to Expand Technology Investment Banking Practice

NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Joel Fishbein will join the firm’s Technology investment banking practice as a Senior ...
WDAF-TV
2mon

Guggenheim Securities Hires David Mell to Expand Retail Investment Banking

NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that David Mell has joined the firm as a Senior Managing Director in its Consumer and Retail ...
ksn.com
2y

Guggenheim Securities Hires Tim Murphy and Alex Kozak to Expand Telecom & Digital Infrastructure Investment Banking Practice

NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Tim Murphy and Alex Kozak will join the firm as a Senior Managing Director, and Managing ...
  • Privacy
  • Terms